Digital Biomarker Study Opens: Wearable Sensors to Track Frontotemporal Dementia Progression — What Neurologists Need to Know
247 Health News Editorial
·14 May 2026
·4 min read
·clinical-trialsNew observational study will use wearable sensors and digital assessments to validate biomarkers for tracking frontotemporal dementia progression over 24 months. The research could revolutionise monitoring of this challenging neurodegenerative condition.
Originally reported by ClinicalTrials.gov
References
- 1.Bang, J., Spina, S., & Miller, B. L. (2015). Frontotemporal dementia. The Lancet, 386(10004), 1672-1682. https://doi.org/10.1016/S0140-6736(15)00461-4
- 2.BioSensics. (2024). A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum. ClinicalTrials.gov. NCT07569367. https://clinicaltrials.gov/study/NCT07569367
- 3.Golbe, L. I., & Ohman-Strickland, P. A. (2007). A clinical rating scale for progressive supranuclear palsy. Brain, 130(6), 1552-1565. https://doi.org/10.1093/brain/awl377
- 4.Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., ... & Grossman, M. (2011). Classification of primary progressive aphasia and its variants. Neurology, 76(11), 1006-1014. https://doi.org/10.1212/WNL.0b013e31821103e6
- 5.Hogan, D. B., Jetté, N., Fiest, K. M., Roberts, J. I., Pearson, D., Smith, E. E., ... & Maxwell, C. J. (2016). The prevalence and incidence of frontotemporal dementia: a systematic review. The Canadian Journal of Neurological Sciences, 43(1), 96-109. https://doi.org/10.1017/cjn.2016.2
- 6.Onyike, C. U., & Diehl-Schmid, J. (2013). The epidemiology of frontotemporal dementia. International Review of Psychiatry, 25(2), 130-137. https://doi.org/10.3109/09540261.2013.776523
- 7.Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., ... & Miller, B. L. (2011). Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain, 134(9), 2456-2477. https://doi.org/10.1093/brain/awr179
- 8.Staffaroni, A. M., Bajorek, L., Casaletto, K. B., Cobigo, Y., Goh, S. M., Wolf, A., ... & Kramer, J. H. (2020). Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia. JAMA Neurology, 77(9), 1153-1163. https://doi.org/10.1001/jamaneurol.2020.0397
2
247 Health News Editorial
247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.
Related Articles
clinical-trials
Digital Health Platform vs Case Manager Support in Hypertension Management: Taiwan's 1,726-Participant Trial Signals a Shift in Blood Pressure Care Delivery
3 Aug 2026
clinical-trials
Phase II Trial: AI-Powered Wysa Chatbot vs Unmet Need — Digital Eating Disorder Prevention in At-Risk Adolescents
3 Aug 2026
clinical-trials
Pilot Trial Targets the Inpatient-to-Outpatient Gap: Digital Smoking Cessation Intervention for Persons With Serious Mental Illness — Key Findings for Clinicians
3 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service